| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DOMA | Common stock | Sale | $44,349 | -81,226 | -1.5% | $0.5460 | 5,291,560 | 06 Sep 2022 | Direct | F1, F2 |
| transaction | DOMA | Common stock | Sale | $73,089 | -134,109 | -0.28% | $0.5450 | 47,119,166 | 06 Sep 2022 | By The Saslaw-Simkoff Revocable Trust | F3, F4, F5 |
| transaction | DOMA | Common stock | Sale | $13,929 | -25,891 | -0.05% | $0.5380 | 47,093,275 | 07 Sep 2022 | By The Saslaw-Simkoff Revocable Trust | F3, F5, F6 |
| holding | DOMA | Common stock | 346,609 | 06 Sep 2022 | By Max Simkoff 2020 GRAT | F7 | |||||
| holding | DOMA | Common stock | 346,609 | 06 Sep 2022 | By Jennifer Saslaw 2020 GRAT | F8 |
| Id | Content |
|---|---|
| F1 | As previously reported, on June 29, 2022 (the "Date of Grant"), the reporting person was granted 2,435,325 restricted stock units ("RSUs") under the Doma Holdings, Inc.'s (the "Company") Omnibus Incentive Plan (the "Plan"), representing the right to receive shares of Company common stock in the future. The grant vests as follows: 1/16th of the total RSUs will vest on each successive Scheduled Vesting Date (as defined below) following the Date of Grant, with a "Scheduled Vesting Date" being September 1, December 1, March 1 and June 1 of the applicable year, provided the reporting person is continuously employed through such date as applicable, with the first 1/16th of the RSUs vesting on September 1, 2022 and the final 1/16th of the RSUs vesting on September 1, 2026. On September 1, 2022, 152,207 shares of such RSUs vested. In connection with this vesting, 81,226 shares were sold on September 6, 2022 to satisfy the reporting person's tax withholding obligations. |
| F2 | The price reported above in Column 4 represents a weighted average purchase price. This transaction was executed in multiple trades at prices ranging from $0.53 to $0.59, inclusive. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022. |
| F4 | The price reported above in Column 4 represents a weighted average sales price. This transaction was executed in multiple trades at prices ranging from $0.53 to $0.59, inclusive. The reporting person hereby undertakes to provide, upon request, to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | These shares are owned directly by The Saslaw-Simkoff Revocable Trust and indirectly by Maxwell Simkoff as trustee of the trust. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
| F6 | The price reported above in Column 4 represents a weighted average sales price. This transaction was executed in multiple trades at prices ranging from $0.53 to $0.56, inclusive. The reporting person hereby undertakes to provide, upon request, to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | These shares are owned directly by the Max Simkoff 2020 GRAT. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
| F8 | These shares are held for the benefit of the reporting person's wife. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |